Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
13 Février 2025 - 8:20PM
Edgar (US Regulatory)
Exhibit A
Pursuant to the instructions in Items 6 and 7 of Schedule 13G, the security being reported on by Nikko Asset Management Americas, Inc., as subsidiary to
the parent holding companies listed below, are owned, or may be deemed to be beneficially owned, by its parent holding companies.
|
1) |
Sumitomo Mitsui Trust Group Inc.
|
|
o |
A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
|
|
o |
A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J).
|
|
2) |
Nikko Asset Management Co., Ltd.
|
|
o |
An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
|
|
o |
A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J).
|
Adaptive Biotechnologies (NASDAQ:ADPT)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
Adaptive Biotechnologies (NASDAQ:ADPT)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025
